slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 3,661-3,690
Pages 395
Rows per page 30
Slide function
3,661-3,690 of 11,828
47
The slide includes a disclaimer regarding the preliminary nature of the Q2 2020 financial results.Berkeley Lights | IPO Presentation Deck | 49 slides · Berkeley Lights
Pitch deck Investment bank Loop · Golden Circle1 hit
05
The slide uses a structured layout to highlight market rankings and key performance metrics for each business unit.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank Beat · Team1 hit
06
LDT likely stands for Laboratory Developed Test.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank 1 hit
07
The slide combines a horizontal timeline with a geographic map and investor logos.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank 1 hit
09
The slide uses a grid-like layout to categorize different types of business traction.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank 1 hit
20
The map visualizes the geographic footprint of regulatory/procurement approvals for Genetron's assays.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
21
The slide uses a flow diagram to illustrate the clinical study methodology and results.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
23
The slide uses a split-layout: left side focuses on clinical study traction, right side focuses on market context and commercialization milestones.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
25
The slide uses a process flow diagram to map services to the drug development lifecycle.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank 1 hit
27
Includes a table of specific industry-leading regulatory approvals and team metrics.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank 1 hit
32
Includes LDT test volume counts above the revenue bars.Genetron | IPO Presentation Deck | 41 slides · Genetron
Pitch deck Investment bank 1 hit
17
The slide combines a geographic map, a table of historical growth metrics, and a logo grid of partners.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
22
The slide uses a table-like structure to map operational categories to specific actions and quantitative outcomes.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
26
The slide uses a consistent color-coding and arrow-based flow to indicate progression across three key business metrics.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank 1 hit
27
The slide highlights significant year-over-year growth in profitability metrics.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank 1 hit
28
The slide uses a combination of a bar chart for revenue/expenses and a line chart for margins to show cohort maturity.Oak Street Health | IPO Presentation Deck | 35 slides · Oak Street Health
Pitch deck Investment bank 1 hit
15
The slide highlights clinical trial results for an autologous product as a stepping stone to allogeneic development.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
16
Uses patient success stories as clinical evidence of product efficacy.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
20
The slide compares autologous (101) vs allogeneic (ALLO1) CAR-T therapy efficacy in tumor reduction.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
21
Slide 20 of a pitch deck, showing longitudinal efficacy data.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
23
Data presented at SITC 2017. Includes both imaging and caliper measurement data.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
24
The slide uses a quadrant key to identify T-cell subsets (Teff, TSCM, Tem, Tcm) and highlights the persistence of TSCM cells post-tumor elimination.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank Beat · Product1 hit
26
The slide uses two line charts to demonstrate efficacy across two different cancer models.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
31
Includes histological images, a dot plot for OTC activity, and a Kaplan-Meier survival curve.Poseida Therapeutics | IPO Presentation Deck | 34 slides · Poseida Therapeutics
Pitch deck Investment bank 1 hit
21
The slide uses a before-after-framing style to contrast efficacy and side-effect profiles.Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank 1 hit
25
The slide uses a circular process diagram to connect the company's funding to its operational milestones.Relay Therapeutics | IPO Presentation Deck | 25 slides · Relay Therapeutics
Pitch deck Investment bank 1 hit
08
The chart displays a transition from actuals (2018-2019) to estimates (2020-2021).Rush Street | SPAC Presentation Deck | 37 slides · Rush Street Interactive
Pitch deck Investment bank Beat · Financials1 hit
16
Uses map-based visualization to demonstrate geographic footprint and market dominance.Rush Street | SPAC Presentation Deck | 37 slides · Rush Street Interactive
Pitch deck Investment bank 1 hit
23
The chart compares LTV/CAC ratios at 5 months, Year 1, and Year 3.Rush Street | SPAC Presentation Deck | 37 slides · Rush Street Interactive
Pitch deck Investment bank 1 hit
25
The slide highlights strong growth metrics and profitability despite a focus on top-line expansion.Rush Street | SPAC Presentation Deck | 37 slides · Rush Street Interactive
Pitch deck Investment bank 1 hit